The Subcommittee on Health and the Subcommittee on Oversight and Investigations held a hearing titled, "H1N1 Preparedness:  An Update of Vaccine Production and Distribution" on Wednesday, November 18, 2009 in 2123 Rayburn House Office Building.  The hearing examined the response to the H1N1 influenza pandemic.

Witnesses:

Panel One:

• Dr. Anne Schuchat, Director, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention
• Dr. Nicole Lurie, Assistant Secretary for Preparedness and Response, Department of Health and Human Services
• Dr. Jesse Goodman, Acting Chief Scientist, Deputy Commissioner for Scientific and Medical Programs, Food and Drug Administration

Panel Two:

• Mr. Paul Perreault, President, CSL Biotherapies, Inc.
• Dr. Vas Narasimhan, President, Novartis Vaccines USA
• Dr. Ben Machielse, Executive Vice President, Operations, MedImmune
• Mr. Phillip Hosbach, Vice President, Immunization Policy and Government Relations, Sanofi Pasteur
• Dr. David Lakey, Commissioner, Texas Department of State Health Services
• Dr. Jeffrey Levi, Executive Director, Trust for America's Health

• Chairman Waxman's Opening Statement
• Chairman Pallone's Opening Statement

• Testimony of Anne Schuchat
• Testimony of Nicole Lurie
• Testimony of Jesse Goodman
• Testimony of Paul Perreault
• Testimony of Vas Narasimhan
• Testimony of Ben Machielse
• Testimony of Phillip Hosbach
• Testimony of David Lakey
• Testimony of Jeffrey Levi

Transcript:

• Preliminary Transcript

Video
WMV

Panel One - Download or Stream
Panel Two - Download or Stream